Submission of Audited Financial Results for the quarter and financial year ended 31 March 2025

Revenue growth above 20%Profit growth above 25%EBITDA margin compressionNegative operating cash flowDebt to equity above the thresholdResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+1.4%Reaction day

₹67.02

prior close

₹67.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.1%+1.3% vs market

Pharmaceuticals peers, median of 147sector-0.1%+1.5% vs sector

On the reaction day the stock moved 1.3 pts more than Nifty Microcap 250 and 1.5 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+6.6

10m

+6.5

15m

+3.6

30m

+4.5

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+1.4+0.1+1.3-0.1+1.5

Next day

-1.6-0.2-1.4-0.2-1.5

-4.9+0.3-5.2-0.2-4.6

-3.9+0.9-4.7+0.0-3.9

-5.5+0.8-6.2+0.0-5.5

-1.8+2.2-4.0+0.6-2.5

-7.9+3.4-11.3+1.4-9.4

15d

-16.4-0.8-15.7-2.9-13.5

-9.2+2.9-12.1+0.3-9.5

-15.0+0.8-15.9-0.4-14.7

-21.0+0.0-21.0-3.2-17.8

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 147Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Roopa Industries Limited (BSE: 530991) reported audited results for Q4 and FY25 with a strong jump in revenue from operations to ₹12,068.70 lakhs, up about 71% from ₹7,042.62 lakhs in FY24. Profit after tax rose roughly 34% to ₹203.49 lakhs (vs ₹151.91 lakhs), pushing EPS to ₹2.57 from ₹1.95, and total income for the year reached ₹12,298.35 lakhs. The statutory auditor, Yelamanchi & Associates, issued an unmodified (clean) opinion on the results, and Q4 standalone PAT stood at ₹41.80 lakhs on revenue of ₹2,983.27 lakhs. However, operating cash flow turned sharply negative at -₹659.36 lakhs (versus +₹200.98 lakhs in FY24) because of a large build-up in inventory and receivables, and EBITDA margin compressed to about 5.2% from 7.8% even as total borrowings climbed to around ₹3,326 lakhs against equity of ₹1,749 lakhs (D/E ~1.9x). The board also appointed Geeta Serwani & Associates as Secretarial Auditor for five years from FY26 to FY30.

Likely market impact

Top-line growth and higher profits are positives, but the swing to negative operating cash flow, thinner margins, and rising debt signal working-capital stress that investors should monitor closely in coming quarters.